National Cancer Centre Japan
In research, National Cancer Centre Japan stands highest in Medicine (#4,454 of 10,443 worldwide) and Health Sciences (#5,939 of 11,982 worldwide), 2022–2025. Relative to its size it is most specialised in Oncology and Pulmonary and Respiratory Medicine — Oncology is 16.0× its share of world research.
- World rank, 2022–2025
- #8,633 of 28,054 · #5,783 all time
- Rank in Japan
- #220 of 1,070
- Research works
- 1.8k ▲ 15% vs 2013–17
- Citations
- 90k 50.1 per fractional work
- Top-10% rate
- 17.2% record average 16.5%
- Open access
- 40% world 28%
What is National Cancer Centre Japan known for in research?
The fields where it stands highest, 2022–2025, ranked among every institution above the floor in each field.
| Field | World rank | Where that sits | Top-10% rate | Works | All time |
|---|---|---|---|---|---|
| MedicineField | #4,454 of 10,443 | 16.5% | 165 | #2646 | |
| Health SciencesDomain | #5,939 of 11,982 | 16.3% | 170 | #3545 |
Each strip is that field’s whole ranked pool, with the notch where National Cancer Centre Japan sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).
What does National Cancer Centre Japan specialise in?
Where its research is concentrated relative to its size: Oncology takes 16.0× the share of its output that it takes of world research.
- OncologySubfield · 39.6 works16×
- Pulmonary and Respiratory MedicineSubfield · 33.5 works9.9×
Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Medicine, 3.9×. Every wedge is a field page.
- Medicine 3.9×
- Biochemistry, Genetics and Molecular Biology 2.4×
- Immunology and Microbiology 2.0×
- Dentistry 1.4×
- Nursing 1.1×
- Pharmacology, Toxicology and Pharmaceutics 0.7×
- Neuroscience 0.7×
- Health Professions 0.5×
- Physics and Astronomy 0.4×
- Psychology 0.2×
- Economics, Econometrics and Finance 0.2×
- Materials Science 0.1×
- Chemistry 0.1×
- Mathematics 0.1×
- Computer Science 0.1×
- Engineering 0.1×
- Decision Sciences 0.1×
- Social Sciences 0.1×
- Arts and Humanities 0.1×
- Business, Management and Accounting 0.1×
- Agricultural and Biological Sciences 0.0×
- Environmental Science 0.0×
Who are the top researchers at National Cancer Centre Japan?
Ranked on the composite score, Masuko Katoh, Masaru Katoh and Yukihiro Nakanishi lead among researchers whose main affiliation is National Cancer Centre Japan.
- 1 Masuko Katoh Japan · #136,839 worldwide 235 citations · 32 works
- 2 Masaru Katoh Japan · #175,765 worldwide 404 citations · 74 works
- 3 Yukihiro Nakanishi Japan · #206,628 worldwide 89 citations · 38 works
- 4 Masami Suganuma Japan · #369,130 worldwide 141 citations · 36 works
- 5 Hitoshi Ichikawa Japan · #404,513 worldwide 89 citations · 26 works
- 6 Minoru Esaki Japan · #424,675 worldwide 40 citations · 30 works
- 7 Shin Takayama Japan · #1,296,302 worldwide 15 citations · 15 works
Which keywords describe research at National Cancer Centre Japan?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Chemotherapy, Prognostic Factors, Clinical Practice Guidelines, Immunotherapy, Radiotherapy, Targeted Therapy, Clinical Trials and Survival Analysis.
- Gastric Cancer
- Tumor Staging
- EGFR Mutations
- Rituximab
- Molecular Profiling
- Tumor Markers
- PD-1 and PD-L1
- Genomic Profiling
- Molecular Classification
- Genetic Mutations
- Soft Tissue Sarcoma
- Osteosarcoma
- Biomarkers
- Neoadjuvant Therapy
- Metastasis
- Tumor Microenvironment
- Clinical Trials
- Epidemiology
- Immunotherapy
- Prognostic Factors
- Chemotherapy
- Clinical Practice Guidelines
- Radiotherapy
- Targeted Therapy
- Survival Analysis
- Cancer
- Breast Cancer
- Quality of Life
- Surgical Management
- PET Imaging
- Adjuvant Therapy
- Molecular Characterization
- Endoscopic Resection
- Immune Checkpoint Blockade
- Treatment Guidelines
- Cancer Incidence
- Lymphoma
- ALK Inhibitors
- Radiation Therapy
- Metastatic
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Chemotherapy36▲ 24×22 topics
- Prognostic Factors22▲ 23×14 topics
- Clinical Practice Guidelines20▲ 17×12 topics
- Immunotherapy20▲ 13×17 topics
- Radiotherapy15▲ 18×12 topics
- Epidemiology15▲ 1.70×52 topics
- Targeted Therapy13▲ 27×4 topics
- Clinical Trials13▲ 8.9×12 topics
- Survival Analysis12▲ 21×6 topics
- Tumor Microenvironment12▲ 12×8 topics
- Cancer12▲ 3.9×35 topics
- Metastasis10▲ 13×10 topics
- Breast Cancer10▲ 18×11 topics
- Neoadjuvant Therapy10▲ 18×5 topics
- Quality of Life9▲ 2.8×22 topics
- Biomarkers8▲ 5.4×10 topics
- Surgical Management7▲ 8.2×11 topics
- Osteosarcoma7▲ 66×1 topic
- PET Imaging7▲ 19×4 topics
- Soft Tissue Sarcoma7▲ 58×1 topic
- Adjuvant Therapy7▲ 25×2 topics
- Genetic Mutations7▲ 7.3×13 topics
- Molecular Characterization7▲ 18×4 topics
- Molecular Classification6▲ 18×4 topics
- Endoscopic Resection6▲ 26×2 topics
- Genomic Profiling6▲ 25×2 topics
- Immune Checkpoint Blockade5▲ 21×1 topic
- PD-1 and PD-L15▲ 21×1 topic
- Treatment Guidelines5▲ 11×4 topics
- Tumor Markers5▲ 29×2 topics
- Cancer Incidence5▲ 17×4 topics
- Molecular Profiling5▲ 23×3 topics
- Lymphoma5▲ 14×3 topics
- Rituximab5▲ 15×2 topics
- ALK Inhibitors5▲ 35×1 topic
- EGFR Mutations5▲ 35×1 topic
- Radiation Therapy5▲ 16×5 topics
- Tumor Staging5▲ 19×2 topics
- Metastatic5▲ 33×2 topics
- Gastric Cancer4▲ 18×3 topics
Which research topics does National Cancer Centre Japan publish most on?
By volume in 2022–2025: Sarcoma Diagnosis and Treatment, Cancer Immunotherapy and Biomarkers, Lung Cancer Treatments and Mutations and Pancreatic and Hepatic Oncology Research.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Sarcoma Diagnosis and Treatment Pulmonary and Respiratory Medicine 7 works
- 2 Cancer Immunotherapy and Biomarkers Oncology 5 works
- 3 Lung Cancer Treatments and Mutations Pulmonary and Respiratory Medicine 5 works
- 4 Pancreatic and Hepatic Oncology Research Oncology 4 works
- 5 Lung Cancer Research Studies Oncology 4 works
- 6 Gastric Cancer Management and Outcomes Pulmonary and Respiratory Medicine 4 works
- 7 Lymphoma Diagnosis and Treatment Pathology and Forensic Medicine 4 works
- 8 Cancer Genomics and Diagnostics Cancer Research 4 works
- 9 HER2/EGFR in Cancer Research Oncology 3 works
- 10 Lung Cancer Diagnosis and Treatment Pulmonary and Respiratory Medicine 3 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has National Cancer Centre Japan's research output changed?
Output in 2018–2022 was 15% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Tokyo
- The University of Tokyo
- Tokyo Institute of Technology
- Keio University
- Waseda University
- Tokyo University of Science
- Nihon University
- Hitachi (Japan)
- NTT (Japan)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.